×

Biotech and Pharmaceuticals Medicine

  • May 17- Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company's drug to treat alopecia areata, a type of hair loss. The FDA had told Concert Pharma that it could begin the trial, but before dosing patients, the agency had asked for more data, Concert Pharma said, adding that...

  • VA Sec.: On our way for making veterans' health system work again

    Veterans Affairs Secretary David Shulkin discusses the issues facing health care for our country's veterans.

  • May 17- Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company's drug to treat alopecia areata, a type of hair loss.

  • J&J CEO: We have to pay attention to out-of-pocket drug costs

    Alex Gorsky, Johnson & Johnson CEO, speaks with CNBC's Meg Tirrell about the company's pharmaceutical business, drug pricing and health-care reform.

  • J&J plans to seek approval of more than 10 new medicines by 2021

    CNBC's Meg Tirrell reports the latest out of Johnson & Johnson's analyst day including the company's growing pharmaceutical business.

  • Final results from two clinical trials showed leg and foot amputations occurred about twice as often in patients with type 2 diabetes treated with Invokana, known also as canagliflozin, as those given a placebo, the FDA said in an announcement posted on its website. The warnings include a boxed warning, reserved for the most serious possible adverse events, the...

  • Permanente Medical Group CEO: American health-care system is simply broken

    Robert Pearl, Permanente Medical Group president & CEO, discusses the issues facing our health-care system now and how the model can be reformed.

  • Moderna Therapeutics recently revealed that it's working on vaccines for the flu and Zika virus and a therapy for heart failure.

  • May 15- A county in New York state has sued Purdue Pharma LP, Johnson& Johnson and other drugmakers, accusing them of engaging in fraudulent marketing that played down the risks of prescription opioid painkillers, leading to a drug epidemic. Those misrepresentations about drugs like Purdue's OxyContin and Endo's Opana ER led Orange County to incur health care,...

  • LA JOLLA, Calif. _ Kura Oncology Inc. on Monday reported a loss of $7.5 million in its first quarter. Kura Oncology shares have climbed 53 percent since the beginning of the year. Keywords: Kura Oncology, Earnings Report.

  • RIYADH, May 14- Saudi Telecom Co has denied that its systems were affected by the ransomware virus that has spread across 150 countries since Friday, responding to photos circulated on social media claiming to show infected STC computers. The photos showed desktop computers displaying the hallmark red window of the WannaCry virus that has locked up more than...

  • Congo investigating suspected Ebola outbreak

    CNBC's Meg Tirrell reports that the World Health Organization has confirmed one laboratory case of Ebola in the Democratic Republic of the Congo.

  • LONDON, May 12- A trial of AstraZeneca's key immunotherapy drug durvalumab showed it reduced disease progression in lung cancer patients, sending the company's shares higher and giving it a lead over rivals as it seeks to transform its oncology business. Shares in AstraZeneca extended gains to be up by 9.1 percent by mid-afternoon, the top FTSE 100 riser,...

  • LONDON, May 12- A trial of AstraZeneca's key immunotherapy drug durvalumab showed it reduced the risk of death from advanced lung cancer, giving it a lead over rivals as it seeks to transform its oncology business. Shares in AstraZeneca were up 4.7 percent by 1000 GMT, the top FTSE 100 riser, and the company said it was in talks with the authorities over plans for...

  • LONDON, May 12- AstraZeneca's key immunotherapy drug durvalumab was shown to reduce the risk of stage III lung cancer worsening or causing death in a trial, the pharmaceutical company said on Friday. The trial results are a boost for a product the company hopes will become a blockbuster drug with sales in the billions of dollars. "These are highly encouraging...

  • LONDON, May 12- AstraZeneca's key immunotherapy drug durvalumab was shown to reduce the risk of stage III lung cancer worsening or causing death in a trial, the pharmaceutical company said on Friday. The trial results are a major boost for a product the company hopes will become a blockbuster drug with sales in the billions of dollars. The drug, which will have the...

  • Merck CEO: We're doing the right studies to make KeyTruda broadly available

    Merck CEO Kenneth Frazier speaks to CNBC's Meg Tirrell about the FDA's approval of the company's lung cancer treatment KeyTruda and the general fight against cancer.

  • *Danish group looking for new drugs "adjacent" to diabetes. LONDON, May 11- Hit by pricing pressure in its core insulin business, Danish drugmaker Novo Nordisk is looking at new treatments for obesity- a major cause of diabetes- to help revive its growth. By contrast, Novo's newly approved anti-obesity injection Saxenda, launched in 2015 and containing the same GLP-1...

  • NEW YORK, May 10- U.S. drugmaker Pfizer Inc said on Wednesday it reached an agreement with Sangamo Therapeutics Inc for rights to its gene therapy programs to treat the rare blood-clotting disorder hemophilia A, under which Pfizer will pay $70 million upfront. Shares of Sangamo jumped 41 percent to $6.15 in after-the-bell trading. Michael Goettler, global...

  • Pharmacist Pharmacy medication

    The high cost of health care in the US is nothing compared to the markup on some prescription medicines. We reveal the most expensive drugs.